Immunoblue, LLC

Potomac, MD Doing business as Immunoblue LLC

UEI
ZGGMBZWMF5H3
CAGE
7KBV3
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
  • Subcontinent Asian (Asian-Indian) American Owned
  • Minority Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
9908 Kentsdale Dr, Potomac, MD 20854, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Immunoblue, LLC's 3 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Engineered glioblastoma-specific t cells using immunostimulatory photothermal nanoparticles - project summary the goal… Grant · R42CA287488 National Cancer Institute $2,241,805
Engineered glioblastoma-specific t cells using immunostimulatory photothermal nanoparticles - project summary the goal… Grant · R41CA287488 National Cancer Institute $399,669
An engineered nanoimmunotherapy for melanoma Grant · R41CA217294 National Cancer Institute $200,001

Quick answers

What is Immunoblue, LLC's UEI?

Immunoblue, LLC's Unique Entity ID (UEI) in SAM.gov is ZGGMBZWMF5H3.

What is Immunoblue, LLC's CAGE code?

Immunoblue, LLC's CAGE code is 7KBV3.

What is Immunoblue, LLC's primary NAICS code?

Immunoblue, LLC's primary NAICS code is 541713 (Research and Development in Nanotechnology).

Where is Immunoblue, LLC located?

Immunoblue, LLC's physical address in SAM.gov is 9908 Kentsdale Dr, Potomac, MD 20854, USA.

Is Immunoblue, LLC registered in SAM.gov?

Yes. Immunoblue, LLC's SAM.gov registration is active through August 18, 2027.

What is Immunoblue, LLC's most recent federal award?

Immunoblue, LLC's most recent federal grant award is Engineered glioblastoma-specific t cells using immunostimulatory photothermal nanoparticles - project summary the goal… (R42CA287488), from National Cancer Institute, on September 3, 2024.

On GovTribe

See Immunoblue, LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login